Search results

En 2023, nous sommes entrés dans la phase suivante de notre parcours de croissance et d'innovation, renforçant notre position en tant qu'entreprise biopharmaceutique de taille moyenne de premier plan. Avec un fort accent sur nos trois domaines thérapeut...

In 2023, we entered the next phase of our journey of growth and innovation, reinforcing our position as a leading mid-sized biopharmaceutical company. With a sharp focus on our three therapy areas of Oncology, Rare Diseases, and Neuroscience, we achieved t...

...

...

Professor David Jones and Professor Valerie McLin were compensated by Ipsen for their time.  ...

As part of our commitment to accelerating transformative research and development, we’re excited to announce that our annual Golden Ticket competition is now open! Through our continued partnership with BioLabs, we’re delighted to be offering the brigh...

Dans le cadre de notre engagement à accélérer l’innovation, nous avons le plaisir d’annoncer que notre concours annuel « Golden Ticket» est désormais ouvert aux candidatures ! Grâce à notre partenariat avec BioLabs, nous sommes heureu...

...

...

When Ioana Parsons, General Manager of the UK & Ireland, thinks about continuous learning, she sees one part of a larger puzzle. “Business performance reflects overall organizational health,” she says. “Plenty of data shows that ‘healthy’ org...